Bruno Gomes
Basel, BS, Switzerland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 29 publications
Mapping immune activity in HPV-negative head and neck squamous cell carcinoma: a spatial multiomics analysis.
Journal: Journal for immunotherapy of cancer
Published: June 11, 2025
Machine learning identifies clinical tumor mutation landscape pathways of resistance to checkpoint inhibitor therapy in NSCLC.
Journal: Journal for immunotherapy of cancer
Published: February 03, 2025
Predicting Survival in Patients with Advanced NSCLC Treated with Atezolizumab Using Pre- and on-Treatment Prognostic Biomarkers.
Journal: Clinical pharmacology and therapeutics
Published: March 14, 2024
Tumor beta2-microglobulin and HLA-A expression is increased by immunotherapy and can predict response to CIT in association with other biomarkers.
Journal: Frontiers in immunology
Published: August 29, 2023
Epigenetic MLH1 silencing concurs with mismatch repair deficiency in sporadic, naturally occurring colorectal cancer in rhesus macaques.
Journal: Journal of translational medicine
Published: August 25, 2023
A Composite Decision Rule of CD8+ T-cell Density in Tumor Biopsies Predicts Efficacy in Early-stage, Immunotherapy Trials.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: May 24, 2023
Facts and Hopes on Biomarkers for Successful Early Clinical Immunotherapy Trials: Innovative Patient Enrichment Strategies.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: May 20, 2023
Spontaneous, naturally occurring cancers in non-human primates as a translational model for cancer immunotherapy.
Journal: Journal for immunotherapy of cancer
Published: December 05, 2022
T-Cell Heterogeneity in Baseline Tumor Samples: Implications for Early Clinical Trial Design and Analysis.
Journal: Frontiers in immunology
Published: August 18, 2021
Doubling down with CAR-T cell cancer immunotherapy: a two-step recognition circuit enables discrimination between target antigen high and low cancer cells.
Journal: Signal transduction and targeted therapy
Published: April 28, 2021
Last Updated: 09/26/2026